Evaluation of new antiemetic agents and definition of antineoplastic agent emetogenicity—an update
✍ Scribed by Steven M. Grunberg; David Osoba; Paul J. Hesketh; Richard J. Gralla; Sussanne Borjeson; Bernardo L. Rapoport; Andreas du Bois; Maurizio Tonato
- Publisher
- Springer-Verlag
- Year
- 2004
- Tongue
- English
- Weight
- 71 KB
- Volume
- 13
- Category
- Article
- ISSN
- 0941-4355
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
The design and evaluation of two new soft anticholinergic agents, ethoxycarbonylphenylcyclopentylacetyl-N,N-dimethyltropinium methyl sulfate (PCMS-1) and methoxycarbonylphenylcyclopentylacetyl-N,N-dimethyltropinium methyl sulfate (PCMS-2) are presented. According to the inactive metabolite approach
Ametantrone acetate (anthracenedione diacetate, NSC 2875 13) is an experimental antineoplastic agent with activity against a comprehensive panel of solid transplantable tumors in mice. The studies reported here were aimed at establishing the toxicologic profile of this drug. Studies in mice and dogs